Continuous low-dose cyclophosphamide plus prednisone in the treatment of relapsed and refractory multiple myeloma with severe complications

BACKGROUND/OBJECTIVE: We retrospectively analyzed the effective and safety of continuous low-dose cyclophosphamide combined with prednisone (CP) in relapsed and refractory multiple myeloma (RRMM) patients with severe complications. METHODS: A total of 130 RRMM patients with severe complications were...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Haotian, Wei, Wei, Peng, Rong, Chen, Haimin, Zhou, Nian, Wu, Lixia, Yu, Wenjun, Zhao, Wenhao, Hou, Jian, Zhou, Fan
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240086/
https://www.ncbi.nlm.nih.gov/pubmed/37284198
http://dx.doi.org/10.3389/fonc.2023.1185991

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10240086/
https://www.ncbi.nlm.nih.gov/pubmed/37284198
http://dx.doi.org/10.3389/fonc.2023.1185991

Ejemplares similares